Organogenesis Holdings Commences Offer to Exchange Class A Common Stock for any and all Outstanding Public Warrants and Consent Solicitation | Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2019 Financial Results on August 9, 2019

Organogenesis Holdings Inc. Receives Positive Nasdaq Listing Determination

Organogenesis.com - News - Press & Announcements

Working at Organogenesis is not ALL business....unless your business is taking the title of Mass Biotech Softball state champs two years in a row. Congratulations to our East Coast family on another stellar year. Now, let's go for three!

Organogenesis Highlights Latest Wound Care Research, Launches New Amniotic Wound Care Product Line and New PuraPly™ Antimicrobial Wound Matrix Small Size at SAWC Fall 2017

Organogenesis Names New Chief Commercial Officer and Chief Operating Officer

Organogenesis Inc. Sponsors American Podiatric Medical Association Education Programs, Annual Scientific Meeting

PuraPly™ Antimicrobial Named One of Top 10 Innovations in Podiatry

Organogenesis Inc. Announces Acquisition of NuTech Medical